In the Pacific region, limited pharmacy competition and distribution costs can affect medication pricing. Zepbound® (Tirzepatide, Injectable pen) by Eli Lilly has been FDA-approved since 2023 for Chronic weight management. Weight Method offers a separate option for Kerman residents: licensed California providers evaluate eligible patients via telehealth and prescribe compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Tirzepatide is not FDA-approved. The Weight Method program is priced at $329/month — same pricing regardless of location.
FDA-approved Zepbound prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · Kerman is already seeing results
Zepbound in Kerman, CA: an FDA-approved GLP-1 medication shown to achieve 15-22% body weight loss in clinical trials. Weight Method offers Zepbound to patients in Kerman from $329/month with virtual consultations and direct-to-door shipping.
Zepbound® by Eli Lilly is the FDA-approved Injectable pen Tirzepatide product, taken Once weekly and approved in 2023 for Chronic weight management. Tirzepatide works by mimicking incretin hormones that regulate hunger and satiety, reducing appetite and helping you feel full with smaller portions. Weight Method is a separate telehealth program for Kerman residents: licensed providers evaluate eligible patients and prescribe compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Tirzepatide is not FDA-approved. The Weight Method program starts at $329/month and includes the provider evaluation, the medication, ongoing care, and home delivery.
Suburban life around Kerman comes with its own weight management challenges — car-dependent commutes, limited walkability, and the convenience of drive-throughs. Tirzepatide therapy addresses biology involved in weight regulation by reducing hunger signals, so Kerman area residents can break patterns that willpower alone cannot fix. Weight Method prescribes compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy, at $329/month, delivered to your door. Compounded Tirzepatide is not FDA-approved.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in California and start Zepbound from $329/month.
Get Started NowFree consultation. No commitment.